A study on the effect of add-on rosiglitazone on the ankle -brachial pressure index of patients with type 2 diabetes mellitus in Hospital Universiti Sains Malaysia
Background Rosiglitazone, an oral hypoglycaemic agent of the thiazolidinedione group is used for Type 2 Diabetes treatment. Research has shown that this medication, being a peroxisome proliferator activator receptor-gamma agonist has effects beyond glycaemic control alone. Apart from improving in...
Saved in:
Main Author: | Mustaffa, Nazri |
---|---|
Format: | Monograph |
Language: | English |
Published: |
Pusat Pengajian Sains Perubatan, Universiti Sains Malaysia
2010
|
Subjects: | |
Online Access: | http://eprints.usm.my/53639/1/Dr%20Nazri%20Mustaffa-Eprints.pdf http://eprints.usm.my/53639/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A study on the effect of add-on rosiglitazone on the ankle-brachial pressure index of
patients with type 2 diabeties mellitus in Hospital Universiti Sains Malaysia
by: Mustaffa, Nazri
Published: (2010) -
A study on the effect of add-on rosiglitazone on the anklebrachial pressure index of patients with type 2 diabetes mellitus in hospital Universiti Sains malaysia
by: Mustaffa, Nazri
Published: (2007) -
Association between ankle-brachial systolic index, pulse oximetry gradient index and CT angiogram of lower limb among type 2 diabetic for detecting peripheral arterial disease
by: Talib, Norain
Published: (2017) -
Combination therapy for optimum glycaemic control : a randomized open label trial comparing rosiglitazone with combination sulphonylureas and metformin tablets in type 2 diabetes mellitus
by: Ghazali, Wan Syamimee Wan
Published: (2006) -
Paraoxonase activity in type 2 diabetes mellitus malay patients in Hospital Universiti Sains Malaysia (HUSM)
by: Ibrahim, Hanim Afzan
Published: (2015)